121 related articles for article (PubMed ID: 31202624)
1. COL1A2 is a TBX3 target that mediates its impact on fibrosarcoma and chondrosarcoma cell migration.
Omar R; Cooper A; Maranyane HM; Zerbini L; Prince S
Cancer Lett; 2019 Sep; 459():227-239. PubMed ID: 31202624
[TBL] [Abstract][Full Text] [Related]
2. The T-box transcription factor 3 is a promising biomarker and a key regulator of the oncogenic phenotype of a diverse range of sarcoma subtypes.
Willmer T; Cooper A; Sims D; Govender D; Prince S
Oncogenesis; 2016 Feb; 5(2):e199. PubMed ID: 26900951
[TBL] [Abstract][Full Text] [Related]
3. The anti-proliferative function of the TGF-β1 signaling pathway involves the repression of the oncogenic TBX2 by its homologue TBX3.
Li J; Ballim D; Rodriguez M; Cui R; Goding CR; Teng H; Prince S
J Biol Chem; 2014 Dec; 289(51):35633-43. PubMed ID: 25371204
[TBL] [Abstract][Full Text] [Related]
4. The T-box transcription factor, TBX3, is a key substrate of AKT3 in melanomagenesis.
Peres J; Mowla S; Prince S
Oncotarget; 2015 Jan; 6(3):1821-33. PubMed ID: 25595898
[TBL] [Abstract][Full Text] [Related]
5. CCN3 increases cell motility and MMP-13 expression in human chondrosarcoma through integrin-dependent pathway.
Tzeng HE; Chen JC; Tsai CH; Kuo CC; Hsu HC; Hwang WL; Fong YC; Tang CH
J Cell Physiol; 2011 Dec; 226(12):3181-9. PubMed ID: 21344378
[TBL] [Abstract][Full Text] [Related]
6. The T-box transcription factor TBX3 drives proliferation by direct repression of the p21(WAF1) cyclin-dependent kinase inhibitor.
Willmer T; Hare S; Peres J; Prince S
Cell Div; 2016; 11():6. PubMed ID: 27110270
[TBL] [Abstract][Full Text] [Related]
7. The oncogenic TBX3 is a downstream target and mediator of the TGF-β1 signaling pathway.
Li J; Weinberg MS; Zerbini L; Prince S
Mol Biol Cell; 2013 Nov; 24(22):3569-76. PubMed ID: 24025717
[TBL] [Abstract][Full Text] [Related]
8. Bone morphogenetic protein-2 enhances the motility of chondrosarcoma cells via activation of matrix metalloproteinase-13.
Hou CH; Hsiao YC; Fong YC; Tang CH
Bone; 2009 Feb; 44(2):233-42. PubMed ID: 19038372
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the T-box transcription factor Tbx3 by the tumour suppressor microRNA-206 in breast cancer.
Amir S; Simion C; Umeh-Garcia M; Krig S; Moss T; Carraway KL; Sweeney C
Br J Cancer; 2016 May; 114(10):1125-34. PubMed ID: 27100732
[TBL] [Abstract][Full Text] [Related]
10. Endothelin-1 enhances cell migration through COX-2 up-regulation in human chondrosarcoma.
Wu MH; Chen LM; Hsu HH; Lin JA; Lin YM; Tsai FJ; Tsai CH; Huang CY; Tang CH
Biochim Biophys Acta; 2013 Jun; 1830(6):3355-64. PubMed ID: 23523690
[TBL] [Abstract][Full Text] [Related]
11. PEG10 counteracts signaling pathways of TGF-β and BMP to regulate growth, motility and invasion of SW1353 chondrosarcoma cells.
Yahiro Y; Maeda S; Shinohara N; Jokoji G; Sakuma D; Setoguchi T; Ishidou Y; Nagano S; Komiya S; Taniguchi N
J Bone Miner Metab; 2019 May; 37(3):441-454. PubMed ID: 30094509
[TBL] [Abstract][Full Text] [Related]
12. Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen.
Ponticos M; Holmes AM; Shi-wen X; Leoni P; Khan K; Rajkumar VS; Hoyles RK; Bou-Gharios G; Black CM; Denton CP; Abraham DJ; Leask A; Lindahl GE
Arthritis Rheum; 2009 Jul; 60(7):2142-55. PubMed ID: 19565505
[TBL] [Abstract][Full Text] [Related]
13. TCF-1 participates in the occurrence of dedifferentiated chondrosarcoma.
Xu X; Tang X; Guo W; Yang K; Ren T
Tumour Biol; 2016 Oct; 37(10):14129-14140. PubMed ID: 27522523
[TBL] [Abstract][Full Text] [Related]
14. CCN6 enhances ICAM-1 expression and cell motility in human chondrosarcoma cells.
Fong YC; Lin CY; Su YC; Chen WC; Tsai FJ; Tsai CH; Huang CY; Tang CH
J Cell Physiol; 2012 Jan; 227(1):223-32. PubMed ID: 21391218
[TBL] [Abstract][Full Text] [Related]
15. The T-Box factor TBX3 is important in S-phase and is regulated by c-Myc and cyclin A-CDK2.
Willmer T; Peres J; Mowla S; Abrahams A; Prince S
Cell Cycle; 2015; 14(19):3173-83. PubMed ID: 26266831
[TBL] [Abstract][Full Text] [Related]
16. The c-Myc/TBX3 Axis Promotes Cellular Transformation of Sarcoma-Initiating Cells.
Damerell V; Ambele MA; Salisbury S; Neumann-Mufweba A; Durandt C; Pepper MS; Prince S
Front Oncol; 2021; 11():801691. PubMed ID: 35145908
[TBL] [Abstract][Full Text] [Related]
17. The tumour suppressor, miR-137, inhibits malignant melanoma migration by targetting the TBX3 transcription factor.
Peres J; Kwesi-Maliepaard EM; Rambow F; Larue L; Prince S
Cancer Lett; 2017 Oct; 405():111-119. PubMed ID: 28757416
[TBL] [Abstract][Full Text] [Related]
18. PMA-induced up-regulation of TBX3 is mediated by AP-1 and contributes to breast cancer cell migration.
Mowla S; Pinnock R; Leaner VD; Goding CR; Prince S
Biochem J; 2011 Jan; 433(1):145-53. PubMed ID: 20942798
[TBL] [Abstract][Full Text] [Related]
19. Basic fibroblast growth factor induces VEGF expression in chondrosarcoma cells and subsequently promotes endothelial progenitor cell-primed angiogenesis.
Tzeng HE; Chen PC; Lin KW; Lin CY; Tsai CH; Han SM; Teng CL; Hwang WL; Wang SW; Tang CH
Clin Sci (Lond); 2015 Jul; 129(2):147-58. PubMed ID: 25735814
[TBL] [Abstract][Full Text] [Related]
20. The T-Box transcription factor 3 in development and cancer.
Willmer T; Cooper A; Peres J; Omar R; Prince S
Biosci Trends; 2017 Jul; 11(3):254-266. PubMed ID: 28579578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]